Yu-Ting Wang

发表

A Qualitative Study Comparing the Assay Performance Characteristics Between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 Scoring Methods in Mucinous Epithelial Ovarian Cancer

Cheng-Ping Yu, Ming-Yung Lee, Chih‐Ping Han, 2014, Medicine.

Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.

Na Ye, Yi Chen, Z. Miao, 2017, Cancer letters.

Acquired resistance of phosphatase and tensin homolog‐deficient cells to poly(ADP‐ribose) polymerase inhibitor and Ara‐C mediated by 53BP1 loss and SAMHD1 overexpression

Z. Miao, Yu-Nan Tian, Hua-Dong Chen, 2018, Cancer Science.

An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy.

Z. Miao, Guangfu Yang, Pingyuan Wang, 2016, Journal of medicinal chemistry.

International trends in primary liver cancer incidence from 1973 to 2007

Ni Li, M. Dai, Jiansong Ren, 2015, BMC Cancer.

Overexpression of optic atrophy 1 protein increases cisplatin resistance via inactivation of caspase-dependent apoptosis in lung adenocarcinoma cells.

Tzei-Yi Lin, I. Chiang, K. Chow, 2012, Human pathology.

Optic atrophy 1 increases cisplatin resistance via inhibition of caspase-dependent cell death

Yang, Y. Chiang, Tzei-Yi Lin, 2010 .

Increased PARP1‐DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1‐DNA trapping is correlated with PARP1 inhibitor's cytotoxicity

Z. Miao, Yu-Nan Tian, Hua-Dong Chen, 2019, International journal of cancer.

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution

M. Wang, Yi Chen, Z. Miao, 2016, Oncotarget.

International trends in primary liver cancer incidence from 1973 to 2007

Ni Li, M. Dai, Jiansong Ren, 2015, BMC Cancer.